Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages - PubMed
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages
M Robert-Guroff et al. J Virol. 1990 Jul.
Abstract
Primary RNA transcripts from the human immunodeficiency virus type 1 (HIV-1) are processed into mature mRNA by a complex series of splicing events. Viral structural proteins and reverse transcriptase are translated from unspliced or singly spliced transcripts. Proteins which control virus replication, including tat, rev, and nef, are translated from transcripts which are the product of multiple splicing. We have analyzed the composition and relative abundance of the latter transcripts in long-term infected cell lines and in acutely infected peripheral blood cells by amplification with the polymerase chain reaction (PCR) followed by Southern blot, molecular cloning, and DNA sequence analyses. In H9 cells chronically infected with the HIV-1 strain HTLV-IIIB, the predominant of the three kinds of transcripts is those coding for nef. Transcripts with coding potential for rev constituted an intermediate fraction of those analyzed, while those for tat accounted for only a small minority. A similar pattern was observed with Southern blots of PCR-amplified transcripts from peripheral blood lymphocytes acutely infected with HTLV-IIIB. The same general pattern was also observed with PCR-amplified transcripts from peripheral blood monocyte-macrophages infected with an HIV-1 strain (BA-L) able to grow to high titers in macrophages. In these cells, however, the apparent major form of nef transcript contained only the first and third exons of the multiply spliced transcripts and appeared to be generated by either a single or a triple splicing mechanism. As with lymphocytes, tat-specific mRNAs were by far the least abundant. It thus appears that different cell types infected with different strains of HIV-1 maintain a similar balance of expression in which transcripts for nef vastly predominate over those for tat and that those for rev are intermediate in abundance.
Similar articles
-
Willard-Gallo KE, Furtado M, Burny A, Wolinsky SM. Willard-Gallo KE, et al. Eur J Immunol. 2001 Apr;31(4):969-79. doi: 10.1002/1521-4141(200104)31:4<969::aid-immu969>3.0.co;2-2. Eur J Immunol. 2001. PMID: 11298321
-
Arrigo SJ, Weitsman S, Rosenblatt JD, Chen IS. Arrigo SJ, et al. J Virol. 1989 Nov;63(11):4875-81. doi: 10.1128/JVI.63.11.4875-4881.1989. J Virol. 1989. PMID: 2677405 Free PMC article.
-
Ranki A, Lagerstedt A, Ovod V, Aavik E, Krohn KJ. Ranki A, et al. Arch Virol. 1994;139(3-4):365-78. doi: 10.1007/BF01310798. Arch Virol. 1994. PMID: 7832642
-
Rev-dependent expression of three species of HIV-1 mRNAs (review).
Fukumori T, Kagawa S, Iida S, Oshima Y, Akari H, Koyama AH, Adachi A. Fukumori T, et al. Int J Mol Med. 1999 Mar;3(3):297-302. doi: 10.3892/ijmm.3.3.297. Int J Mol Med. 1999. PMID: 10028055 Review.
-
Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes.
Karn J. Karn J. Curr Opin Immunol. 1991 Aug;3(4):526-36. doi: 10.1016/0952-7915(91)90016-t. Curr Opin Immunol. 1991. PMID: 1755979 Review.
Cited by
-
In vivo anti-tumor effect of expressing p14ARF-TAT using a FGF2-targeted cationic lipid vector.
Niu G, Driessen WH, Sullivan SM, Hughes JA. Niu G, et al. Pharm Res. 2011 Apr;28(4):720-30. doi: 10.1007/s11095-010-0353-x. Epub 2011 Jan 19. Pharm Res. 2011. PMID: 21246396
-
Luo T, Garcia JV. Luo T, et al. J Virol. 1996 Sep;70(9):6493-6. doi: 10.1128/JVI.70.9.6493-6496.1996. J Virol. 1996. PMID: 8709288 Free PMC article.
-
Brady HJ, Pennington DJ, Miles CG, Dzierzak EA. Brady HJ, et al. EMBO J. 1993 Dec 15;12(13):4923-32. doi: 10.1002/j.1460-2075.1993.tb06186.x. EMBO J. 1993. PMID: 8262036 Free PMC article.
-
Models for predicting effective HIV chemoprevention in women.
Nicol MR, Emerson CW, Prince HM, Nelson JA, Fedoriw Y, Sykes C, Geller EJ, Patterson KB, Cohen MS, Kashuba AD. Nicol MR, et al. J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):369-76. doi: 10.1097/QAI.0000000000000472. J Acquir Immune Defic Syndr. 2015. PMID: 25501616 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials